Marker Therapeutics
Business Services · Texas, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
9350 Kirby Dr Ste 300, Houston, Texas, 7...Phone Number
(713) 400-6400Website
www.markertherapeutics.comRevenue
-Stock Symbol
MRKRIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
2
1
1
About Marker Therapeutics
Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications. They are headquartered in Houston, Texas.Explore more
Marker Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Marker Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Marker Therapeutics had a recent Job posting/layoffs
Earning: See what the market has to say on Marker Therapeutics recently announced quarterly report
Marker Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Marker Therapeutics launches new products
Check if Marker Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Check out if Marker Therapeutics is spiking on competitors!
Funding: Get notified immidiatlly once Marker Therapeutics has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Marker Therapeutics
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at Marker Therapeutics
Find 2 more new buyers
Compare Similar Companies to Marker Therapeutics
Compare insights from companies similar to Marker Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Marker Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Marker Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Marker Therapeutics.
Marker Therapeutics Tech Stack
A closer look at the technologies used by Marker Therapeutics
See more technologies
Most Recent Scoops
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
Earnings
Earnings, Finance
Earnings
Earnings, Finance
Funding
Project
Spending/Investment, Funding
Funding
Project
Spending/Investment, Funding
Marker Therapeutics News & Media
Marker Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
HOUSTON, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Marker Therapeutics, Inc. (Nasdaq: MRKR), a clinical-stage immuno-oncology company focusing on developing next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications, today announced that its Chief Executive Officer, Dr. Juan Vera, will present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference, being held in a virtual format on February 25-26, 2026.Good Morning America Features Baylor College of Medicine Pancreatic Cancer Study Utilizing Marker Therapeutics’ MAR-T Cell Technology
National broadcast highlights the need for new approaches in one of the deadliest forms of cancer National broadcast highlights the need for new approaches in one of the deadliest forms of cancerBaylor College of Medicine Publishes Promising Safety and Efficacy Results of Multi-Antigen Targeted T Cells in Patients with Pancreatic Cancer
Clinical study from Baylor College of Medicine demonstrates a favorable safety profile and up to 84.6% disease control rate in patients with pancreatic cancer in Arm A of the clinical studyMarker Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Updates
APOLLO study showed encouraging overall responses and favorable safety profile in relapsed/refractory B-cell lymphoma
Read more news
Top Business Services Companies
See more top companies
Frequently Asked Questions Regarding Marker Therapeutics
Sign Up For FreeTo access detailed company insights
Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications. They are headquartered in Houston, Texas.... Read More
